Evidence map›Paper›PMID 27134481›Full record

ArticleJournal of mid-life health

Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection.

Vishal R Tandon, Shamiya Sadiq, Vijay Khajuria, Annil Mahajan, Sudhaa Sharma, Zahid Gillani

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of mid-life health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Blue Nail Discoloration: Literature Review and Diagnostic Algorithms.American journal of clinical dermatology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vishal R TandonDepartment of Pharmacology and Therapeutics, Government Medical College, Jammu City, Jammu and Kashmir, India.
Shamiya SadiqDepartment of Pharmacology, Government Medical College, Jammu City, Jammu and Kashmir, India.
Vijay KhajuriaDepartment of Pharmacology, Government Medical College, Jammu City, Jammu and Kashmir, India.
Annil MahajanDepartment of Internal Medicine, Government Medical College, Jammu City, Jammu and Kashmir, India.
Sudhaa SharmaDepartment of Obstetrics and Gynecology, Government Medical College, Jammu City, Jammu and Kashmir, India.
Zahid GillaniDepartment of Pharmacology, Government Medical College, Jammu City, Jammu and Kashmir, India.
Government Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zidovudine is an important component of first-line antiretroviral treatment regimens used to manage HIV and tuberculosis (TB) co-infection. Nail pigmentation is documented both in adult as well as pediatric HIV patients, but to the best of our knowledge, it has not been reported in 45-year-old women of HIV/TB co-infection. Such an adverse drugs reactions (ADR), although is harmless and reversible, psychological aspects of such ADR may be immense to the extent that it can negatively affect the compliance and result in therapeutic failure. Thus, it is worth reporting.

Indexed as

Adverse drugs reactionsHIV and tuberculosis co-infectionnail hyper-pigmentationZidovudine

Identifiers

PMID27134481
PMCPMC4832895
OpenAlexW2327282120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.